Invention Grant
- Patent Title: Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitors
- Patent Title (中): 咪唑并[1,2-A]吡啶化合物作为VEGF-R2抑制剂
-
Application No.: US11816416Application Date: 2006-02-23
-
Publication No.: US07666879B2Publication Date: 2010-02-23
- Inventor: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander McLean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Mai Yip , Boyu Zhong
- Applicant: David Anthony Barda , Timothy Paul Burkholder , Joshua Ryan Clayton , Yan Hao , James Robert Henry , John Monte Knobeloch , Johnathan Alexander McLean , David Mendel , Mark Edward Rempala , Zhao-Qing Wang , Yvonne Yee Mai Yip , Boyu Zhong
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Elizabeth A. McGraw; Tina M. Tucker
- International Application: PCT/US2006/006283 WO 20060223
- International Announcement: WO2006/091671 WO 20060831
- Main IPC: A01N43/42
- IPC: A01N43/42 ; A61K31/44 ; C07D471/02 ; C07D491/02 ; C07D498/02 ; C07D513/02 ; C07D515/02 ; C07D401/00
![Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitors](/abs-image/US/2010/02/23/US07666879B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides compounds that are inhibitors of VEGF-R2 of the formula: (I) and methods of using these compounds.
Public/Granted literature
- US20090227622A1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS VEGF-R2 INHIBITORS Public/Granted day:2009-09-10
Information query
IPC分类: